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Staphylococcus aureus is a leading cause of bacterial infections globally in both
healthcare and community settings. The success of this bacterium is the product of an
expansive repertoire of virulence factors in combination with acquired antibiotic
resistance and propensity for bioﬁlm formation. S. aureus leverages these factors to
adapt to and subvert the host immune response. With the burgeoning ﬁeld of
immunometabolism, it has become clear that the metabolic program of leukocytes
dictates their inﬂammatory status and overall effectiveness in clearing an infection. The
metabolic ﬂexibility of S. aureus offers an inherent means by which the pathogen could
manipulate the infection milieu to promote its survival. The exact metabolic pathways that
S. aureus inﬂuences in leukocytes are not entirely understood, and more work is needed
to understand how S. aureus co-opts leukocyte metabolism to gain an advantage. In this
review, we discuss the current knowledge concerning how metabolic biases dictate the
pro- vs. anti-inﬂammatory attributes of various innate immune populations, how S.
aureus metabolism inﬂuences leukocyte activation, and compare this with other
bacterial pathogens. A better understanding of the metabolic crosstalk between S.
aureus and leukocytes may unveil novel therapeutic strategies to combat these
devastating infections.
Keywords: Staphylococcus aureus, bioﬁlm, immunometabolism, macrophage, myeloid-derived suppressor
cell, lactate

INTRODUCTION
Staphylococcus aureus (S. aureus) is an opportunistic pathogen that colonizes approximately onethird of the human population and can cause invasive disease at an array of different sites
throughout the body, including endocarditis, skin and soft tissue infection, bacteremia,
pneumonia, osteomyelitis, and medical implant-associated infection (1, 2). The ability to
successfully infect and persist in such a wide range of tissue niches is due to a number of
characteristics that allow the bacterium to evade immune-mediated clearance. Such attributes
include the production of various toxins, the acquisition of antibiotic resistance or tolerance, and the
ability to form bioﬁlm (3–6). Each of these factors, often in combination with one another,
contribute to the ability of S. aureus to counteract immune effector mechanisms.
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Throughout the course of an infection, both host and
pathogen undergo substantial changes in their metabolic
programs to facilitate the production of different effector
molecules that aid in their respective goals (7, 8). In the case of
leukocytes, this takes the form of regulating the production of
cytokines, such as IL-1b. For S. aureus, metabolic
reprogramming allows for the production of various
leukocidins and lactate, among other virulence factors, that
combat the immune system (9). As an infection progresses,
nutrient concentrations within the tissue milieu can rapidly
ﬂuctuate as host and pathogen compete for the same
extracellular energy sources (10, 11). The intrinsic metabolic
ﬂexibility of S. aureus allows it to quickly adapt to these evolving
conditions to promote its survival (12, 13). While S. aureus may
be able to overcome the depletion of speciﬁc nutrient sources, the
leukocyte population may not be as ﬂexible. As metabolism is
inextricably linked to immune cell function, the intentional
depletion and/or release of speciﬁc metabolites that can impair
leukocyte microbicidal activity could represent a system by
which the bacteria inﬂuences host cell metabolism to its
beneﬁt. Here we provide an overview of how S. aureus
interacts with leukocytes at the metabolic level. We will focus
on immunomodulatory metabolites and how they contribute to
the crosstalk between host and pathogen during an infection,
with a particular emphasis on S. aureus bioﬁlm formation. We
also provide examples of metabolic crosstalk between leukocytes
and other bacterial species as further mechanisms to consider in
the context of S. aureus infection.

IMMUNOMETABOLISM
The study of immunometabolism is focused on linking changes
in metabolic programs to effector functions. Over the years, it has
become apparent that activated leukocytes experience a shift in
metabolism that regulates inﬂammatory mediator production
(14–16). Activation usually coincides with a metabolic shift from
the energy (ATP)-rich resting state to an increase in the
production of effector metabolites necessary for biosynthetic
processes for inﬂammatory effector function, such as fatty acid
biosynthesis for prostaglandin production (Figure 1) (17–20).
Since this observation was made, there has been considerable
interest in deﬁning metabolic programs that are characteristic of
either the pro- or anti-inﬂammatory status of various leukocyte
populations. Much of this fervor originated from the idea that
immune cell function could potentially be orchestrated via the
manipulation of the nutrient milieu or by therapeutically
targeting speciﬁc metabolic pathways.
In the context of an infection, immunometabolism is only half
of the story, since pathogens must also acquire essential nutrient
sources for their survival (21). This leads to direct competition
between the host and pathogen on a metabolic scale. Much like
responding leukocytes, S. aureus must also undergo some degree
of metabolic adaptation to counteract the effects of the immune
response. Switching between alternative forms of metabolism is
common in S. aureus due to its signiﬁcant degree of metabolic
plasticity (22–24). This ﬂexibility greatly increases the chances
that the bacteria will win the battle of attrition between host and

FIGURE 1 | Metabolic shifts in leukocytes deﬁne resting from inﬂammatory states. Immune cells normally respire under resting conditions to provide sufﬁcient energy
(ATP) for survival. Upon activation, although energy production is somewhat increased, a signiﬁcant portion of the metabolic ﬂow is dedicated to producing metabolic
intermediates (Effector Metabolites) that are used to generate inﬂammatory mediators (i.e. cytokines, inﬂammatory lipids, etc.) to promote leukocyte effector functions
(Immune Response). S. aureus, either through competition for metabolic resources or by releasing immunomodulatory metabolites, can interfere with this process to
disrupt a productive immune response. Monocyte (MO), macrophage (Mj), neutrophil (PMN), and granulocytic myeloid-derived suppressor cell (G-MDSC). Figure
created with BioRender.
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pathogen for speciﬁc nutrient sources. If this ability to shift
between different metabolic modes is compromised, it could
drastically alter the landscape of an infection. For instance, work
from our laboratory has established that S. aureus bioﬁlm skews
leukocytes towards an anti-inﬂammatory phenotype in a murine
model of prosthetic joint infection (PJI) that is mediated, in part,
by IL-10 production (25–28). Recent work demonstrated that the
loss of an essential metabolic process in S. aureus, such as ATP
synthesis (DatpA), signiﬁcantly decreased the chronicity of
bioﬁlm infection by eliciting a heightened pro-inﬂammatory
response (29). This is likely attributable to the respiratory
defect in S. aureus DatpA that limits the energy required for
virulence factor production (30), which subsequently led to
increased leukocyte viability and pro-inﬂammatory activity
(29). Another group has shown that metabolic adaptation of
Pseudomonas aeruginosa is essential for establishing chronic
bioﬁlm infection in patients with debilitating diseases such as
cystic ﬁbrosis (CF). Host-adapted P. aeruginosa strains
preferentially utilized the tricarboxylic acid (TCA) cycle to
limit stress from reactive oxygen species (ROS) produced by
leukocytes in the airway. This TCA metabolic bias in P.
aeruginosa enhanced bioﬁlm formation, which served to
increase the chronicity of infection (31). How metabolic
changes can inﬂuence the function of various leukocyte
populations and an overview of critical S. aureus metabolic
pathways in the host will be discussed in the following sections.

MACROPHAGE METABOLISM
The macrophage is currently the prototypical cell studied in the
immunometabolism ﬁeld. Much progress has been made in
characterizing how macrophages shift their metabolism after
exposure to various stimuli in vitro and how this inﬂuences
their effector functions. These experiments led to the discovery
that pro- and anti-inﬂammatory polarized macrophages have
distinct metabolic programs (32–34). For example, exposure to
Toll-like receptor (TLR) agonists such as bacterial lipoproteins,
peptidoglycan, DNA, or lipopolysaccharide (LPS) biases
macrophages towards glycolysis. In contrast, anti-inﬂammatory
cytokines (i.e. IL-4 or IL-10) or growth factors promote oxidative
phosphorylation (35, 36). In pro-inﬂammatory macrophages, the
increase in glycolytic metabolism following TLR activation is due,
in part, to two TCA cycle blocks (Figure 2) (15, 35). These break
points create an anaplerotic cycle that leads to the progressive
accumulation of metabolites such as succinate and aconitate,
which are immunomodulatory in nature. Initial experiments
showed that the intracellular concentration of succinate
dramatically increases following TLR stimulation (37–39). Early
work into understanding metabolic reprogramming found that
this succinate pool was diverted from normal TCA cycle
metabolism and oxidized by succinate dehydrogenase (SDH) to
produce high amounts of ROS, which stabilized the transcription
factor hypoxia-inducible factor-1a (HIF-1a) by preventing its

FIGURE 2 | Macrophage metabolic remodeling during an immune response. Following Toll-like receptor (TLR) activation, macrophages undergo metabolic rewiring
to promote inﬂammatory mediator production. The TCA cycle breaks at two points, isocitrate dehydrogenase (IDH) that causes the accumulation of aconitate, which
is converted by immune responsive gene 1 (IRG1) to form itaconate, and succinate dehydrogenase (SDH) that leads to succinate accumulation. While this process
normally augments proinﬂammatory activity, excess itaconate production eventually causes a shift to promote the expression of anti-inﬂammatory genes. Figure
created with BioRender.
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cytoplasmic protein targets, namely Kelch-like ECH-associated
protein 1 (KEAP1) (61–63). Under homeostatic conditions,
KEAP1 is bound to nuclear factor erythroid 2-related factor 2
(Nrf2), which targets the complex for proteasomal degradation.
Under stress conditions, such as S. aureus-induced toxin action,
the complex dissociates and Nrf2 translocates to the nucleus
where it acts as a transcription factor for numerous antiinﬂammatory genes (64). Itaconate is capable of disrupting the
KEAP1-Nrf2 association via alkylation of cysteine residues in
KEAP1 to promote Nrf2 nuclear translocation and the
transcriptional activation of anti-inﬂammatory genes. Via this
mechanism, itaconate represents a way to counterbalance the
proinﬂammatory activity of succinate accumulation (65, 66).
Amino acid metabolism is also important for inﬂuencing
macrophage polarization, where arginine is differentially utilized
by macrophages to exert distinct effector functions (67). For
example, in response to planktonic S. aureus and other proinﬂammatory stimuli, macrophages utilize arginine to drive
inducible nitric oxide synthase (iNOS) activity and nitric oxide
(NO) production (68). Nitric oxide is a highly reactive free
radical that exerts potential bactericidal activity by inducing
DNA and membrane damage as well as targeting oxidative
metabolism (69–71). However, S. aureus is capable of evading
host NO production, which differentiates it from other
Staphylococcal species. One example is ﬂavohemoprotein
(hmp) expression that allows S. aureus to detoxify its
environment by converting NO into nitrate, making it an
iNOS-dependent virulence determinant (72). Another
component of the nitrosative stress response in S. aureus is Llactate dehydrogenase (ldh1), which is a NO-inducible gene.
While hmp serves to detoxify the environment, Ldh allows S.
aureus to maintain redox homeostasis by promoting the
conversion of pyruvate to lactate (73). Although this metabolic
program generates less ATP compared to oxidative metabolism,
it provides a mechanism by which S. aureus can maintain its
reducing equivalents until Hmp can decrease NO levels. In
contrast to iNOS, arginine is used by arginase-1 (Arg-1) in
anti-inﬂammatory polarized macrophages to produce
ornithine. Ornithine is further metabolized into polyamines
and proline for wound repair and cell growth processes (74,
75). Increased Arg1 expression has been linked to macrophage
anti-inﬂammatory activity during S. aureus bioﬁlm infection
(76–78). To determine if Arg1 expression was required for the
immune suppression associated with S. aureus bioﬁlm infection,
our laboratory utilized Arg-1ﬂ/ﬂ; Tie-2Cre conditional knockout
mice where myeloid cells lacked Arg-1. Arg1 was dispensable for
myeloid immunosuppression during bioﬁlm formation but was
critical for S. aureus containment during abscess formation (79).
This was in agreement with a prior study showing that host
polyamine production was important for controlling S. aureus
growth in a mouse SSTI model (80). Taken together, these results
indicate that the effects of Arg1 expression are context-dependent
in terms of myeloid cell function during S. aureus bioﬁlm vs.
planktonic infection.
Monocyte/macrophage metabolism was recently shown by
our laboratory to be important for inﬂuencing the outcome of S.

ubiquitination and degradation (40–44). HIF-1a stabilization
leads to the production of pro-IL-1b, which is cleaved into its
mature form by the NOD-like receptor pyrin domain containing 3
(NLRP3) inﬂammasome (45–47). A secondary effect of this
process is the HIF-1a-dependent induction of glycolytic
enzymes by that feed back to promote biosynthetic pathways to
augment pro-inﬂammatory activity (40, 48, 49). Increased
glycolysis serves to produce ATP and sustain the mitochondrial
membrane potential that is necessary for succinate oxidation.
In macrophages, NLRP3 inﬂammasome activation generally
occurs via a two signal model (45). Signal 1 is mediated by TLR,
IL-1R, or TNFR activation that elicits maximal expression of
pro-IL-1b and inﬂammasome components. Numerous stimuli
have been shown to provide signal 2 and the diverse structure of
these molecules has led to the concept that cellular stress is a
unifying factor responsible for NLRP3 inﬂammasome activation
(45). With regard to S. aureus, a-toxin acts as signal 2 to activate
a primed NLRP3 inﬂammasome (50). This has been attributed to
K + efﬂux from cells as a consequence of toxin-mediated
membrane disruption, which can be potentiated by gasdermin
D cleavage by the NLRP3 inﬂammasome that forms another
transmembrane pore leading to pyroptosis (51). However, in vivo
studies have shown that a-toxin alone is not sufﬁcient for NLRP3
activation. Another requisite is S. aureus lipoproteins that
provide signal 1 via TLR2 activation to elicit maximal
expression of pro-IL-1b and inﬂammasome components (52).
Recently, it was shown that S. aureus packages its pore-forming
toxins into extracellular vesicles that are then internalized by
immune cells. Upon uptake, S. aureus-derived vesicles contain all
of the requisite factors to induce inﬂammasome activation, thus
providing the bacteria with another mechanism to modulate the
immune response (53). A paradox is why S. aureus augments
NLRP3 inﬂammasome activation given its ability to produce the
pro-inﬂammatory cytokines IL-1b and IL-18. However, a recent
study has demonstrated that S. aureus a-toxin exploits NLRP3
inﬂammasome activation in macrophages by recruiting
mitochondria away from the phagosome, which inhibits
mitochondrial ROS production via complex II (SDH) of the
electron transport chain (ETC), phagosomal acidiﬁcation, and
bacterial killing (54). This effect was independent of NLRP3mediated IL-1b and IL-18 production. Intriguingly, this
represents another mechanism that S. aureus exploits to
prevent immune-mediated clearance.
Subsequent in vitro studies examining the mechanisms of
macrophage metabolic remodeling revealed that the increase in
succinate following TLR activation was due to the action of
itaconate, a derivative of the TCA intermediate aconitate.
Itaconate is produced by immune-responsive gene 1 (IRG1)
and as the concentration of itaconate increases, SDH is
progressively inhibited. This leads to succinate accumulation
and decreased oxygen consumption via the inhibition of SDH,
which is also complex II of the mitochondrial ETC (Figure 2)
(55–59). Although the initial production of itaconate augments
macrophage pro-inﬂammatory activity, its accumulation begins
to exert anti-inﬂammatory effects (60). As itaconate accumulates,
it is transported out of mitochondria where it can interact with
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aureus bioﬁlm infection in a mouse model of PJI (81). S. aureus
bioﬁlm biased monocytes towards oxidative metabolism which,
much like macrophages exposed to bioﬁlm in vitro, were largely
anti-inﬂammatory in nature (82). Therefore, a nanoparticle
approach was used to deliver oligomycin, an inhibitor of
complex V of the ETC, to redirect monocyte metabolism
towards glycolysis. Oligomycin nanoparticles augmented
monocyte pro-inﬂammatory activity, which coincided with
reduced bioﬁlm burden in vivo, indicating that metabolic
remodeling could prove to be an effective therapeutic approach
for chronic bioﬁlm infection (81). Importantly, monocyte
metabolic reprogramming was capable of attenuating an
established bioﬁlm infection, whose efﬁcacy was heightened by
concominant antibiotic treatment.

fermentative metabolism and lactate production (23), which
shapes the metabolic attributes of inﬁltrating leukocytes, which
is discussed below.
MDSCs are a heterogenous population of immature myeloid
cells that are grouped into two categories based on their shared
characteristics with mature monocytes or neutrophils, namely
M-MDSCs and G-/PMN-MDSCs (97–99). Both subsets are
thought to exert their suppressive activity through increased
ROS production, although M-MDSCs can also utilize Arg-1 to
deplete arginine that is required for TCR expression to
inhibit T cell activation (94, 100, 101). Although MDSCs
have been best characterized in cancer, they have also been
implicated in promoting chronic infection, including S. aureus
bioﬁlm (25–28), bone, and skin infection (102, 103). Due to
the extensive heterogeneity of MDSCs and context-dependent
modes of action, describing a singular metabolic program that is
characteristic of these cells has proved challenging. Nevertheless,
a few reports have examined MDSC metabolism and how
this affects their suppressive activity (104–106). One study
found that M-MDSCs suppress T cell activation by inhibiting
glycolysis through direct physical contact. Interestingly,
M-MDSCs were metabolically dormant, characterized by
an accumulation of the a-dicarbonyl methylglyoxal.
Methylglyoxal was found in T cells following co-culture with
M-MDSCs and treatment with dimethylbiguanide (DMBG),
which neutralizes dicarbonyls, restored T cell activation,
supporting the importance of methylglyoxal in MDSCmediated T cell suppression (107, 108). Another study
has pointed to fatty acid accumulation and subsequent
prostaglandin production as a metabolic mechanism for
MDSC suppression. Speciﬁcally, PMN-MDSCs overexpress a
fatty acid transporter (FATP2), which led to fatty acid
accumulation and prostaglandin E2 (PGE2) production that
promoted their immunosuppressive effects (109). These studies
highlight the metabolic diversity that MDSCs can adopt to
inﬂuence their inhibitory activity. S. aureus bioﬁlm elicits GMDSCs that may utilize a distinct metabolic program to exert
their suppressive effects than those described here, which
remains to be determined. Further investigation into how
MDSC metabolism evolves throughout the course of infection
is required to appreciate the role that these cells play in shaping
the host immune response.

GRANULOCYTE METABOLISM
Although much progress has been made in understanding the
role of metabolism in macrophages, comparatively less is known
about how metabolic changes affect granulocyte function.
Neutrophils have been shown to rely almost entirely on
glycolytic modes of metabolism to fuel their effector functions,
which agrees with a reduced mitochondrial abundance (83, 84).
Similar to pro-inﬂammatory macrophages, activated neutrophils
adopt a metabolic program that is similar to the aerobic
glycolysis that was ﬁrst described by Otto Warburg in the
1920’s (85), which has since become known as “Warburg
metabolism” (86, 87). This heavy reliance on glycolysis, even in
oxygen replete conditions, is necessary to increase carbon
ﬂux through the pentose phosphate pathway (PPP) to increase
the NADPH pool that is required for NADPH oxidase activity
and ROS production (16, 88). Like pro-inﬂammatory
macrophages, metabolic intermediates from the TCA cycle
that is fueled by glycolysis, are used for anabolic processes to
promote granulocyte functional activity. For example, citrate
from the TCA cycle can be diverted for fatty acid synthesis to
drive the production of pro-inﬂammatory mediators such as
prostaglandins and leukotrienes (89–92). Although granulocytes
are typically considered as purely glycolytic, some studies have
also identiﬁed granulocytes that instead utilize mitochondrial
oxidative metabolism (93). In the context of cancer, glucose
within the tumor microenvironment can quickly become a
limiting factor. Under these conditions, a population of
immature, c-Kit + neutrophils has been shown to utilize
fatty acid oxidation to maintain ROS production by NADPH
oxidase (93). These immature neutrophils in tumor-bearing mice
were regulated through aberrant SCF/c-Kit signaling and
metabolically adapted for the lack of glucose within the tumor
microenvironment. Functionally, this meant the adapted
neutrophils retained the ability to produce ROS, which can
interfere with CD4+ T cell anti-tumor activities (94–96).
Although not deﬁnitively established, these c-Kit+ neutrophils
possess many characteristics of granulocytic MDSCs (G-MDSCs,
see below). A similar reduction in glucose availability occurs
during S. aureus bioﬁlm formation, as reﬂected by a shift towards
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HOST–PATHOGEN METABOLIC
CROSSTALK
In an infectious milieu, not only will leukocytes and the pathogen
have to compete for the same nutrient sources, but this also
creates a new environment in which the two could interact. For
instance, a recent study demonstrated how host adapted strains
of P. aeruginosa responded to the secretion of itaconate by
selecting for variants that were able to utilize the host-derived
metabolite as a nutrient source (110). This selection process
coincided with modiﬁcations of membrane structural
components in P. aeruginosa to augment host-derived
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available nutrient resources in a hierarchical manner (117–119).
S. aureus uses two catabolite control proteins (CcpA & CcpE) to
modulate glucose utilization through central carbon metabolism.
In glucose replete conditions, oxidative metabolism is repressed
by CcpA, which inhibits the expression of critical TCA cycle
enzymes (120–122). As glucose becomes depleted, CcpA activity
is reduced which induces the TCA cycle and citrate production.
Citrate is sensed by CcpE, which bolsters TCA cycle activity and
increases the expression of S. aureus virulence factors (123, 124).
It has been shown that S. aureus can quickly outcompete host
keratinocytes for available glucose, which leads to keratinocyte
death by pyroptosis (125, 126). Pyroptosis fails to clear S. aureus
infection because NLPR3 inﬂammasome activation by ahemolysin redirects mitochondria away from bacteriacontaining phagosomes, thereby preventing acidiﬁcation and
killing (54). Thus, pyroptosis is beneﬁcial for the bacteria
because it promotes its intracellular escape and dissemination,
while simultaneously introducing any host-derived metabolic
intermediates into the infection milieu to be utilized for pathogen
survival and replication.
The importance of this battle for glucose is particularly
relevant in the setting of diabetes. Diabetic patients are
characterized by hyperglycemia and often present with
persistent and invasive S. aureus infections (127, 128). A recent
study examining S. aureus SSTI in a diabetic mouse model has
shown that although there is more bioavailable glucose in
diabetic tissues, phagocytes failed to take up the carbohydrate
with either GLUT-1 or GLUT-3 transporters. This resulted in
impaired oxidative burst activity and increased bacterial burden
(129). S. aureus infection in diabetic patients has been linked to
an increase in the recruitment of low-density neutrophils (LDNs)
(130). LDNs are associated with increased rates of NETosis, or
the production of neutrophil extracellular traps (NETs).
Although, NETs are typically considered to exert antimicrobial effects, elevated levels of NETosis have been linked
to impaired wound healing in patients with diabetes, whose
neutrophils are more prone to NET formation (131). Increased
NETosis in diabetic patients could result from the elevated levels
of glucose within diabetic tissues, as glucose is a metabolic
requirement for the process. Of note, MDSCs that are
expanded in the blood of tumor patients have been
characterized as LDNs (132, 133). By extension, it is intruging
to speculate that the LDNs described in diabetic patients are
actually MDSCs, which might explain why these individuals are
more prone to chronic and recurrent S. aureus infections,
although this remains to be determined.

itaconate release, thereby establishing a positive feedback loop to
promote chronic infection. This illustrates the importance of not
only considering the metabolism of either the host or pathogen
in isolation, but also the byproducts that they excrete and
exchange. Such molecules constitute a new avenue for cellular
signaling that the host and/or pathogen could leverage to their
beneﬁt during infection. These systems become even more
complex in the context of polymicrobial infections, a common
occurrence with P. aeruginosa and S. aureus in the lungs of CF
patients (111–113). With the additional layering of another
organism, the potential number of molecules and interactions
increases exponentially.

S. AUREUS METABOLISM AND
COMPETITION FOR NUTRIENTS
Competition for the various nutrient sources in an infectious
milieu is probably the most intuitive level by which metabolic
crosstalk occurs. In an infection, there are at least two entities (i.e.
host and pathogen) racing to consume the same resources, which
becomes more complicated in the context of polymicrobial
infections. Glucose and oxygen are among the ﬁrst resources
that become restricted in these settings and their deprivation can
be enough to bias the actions of responding immune cells or
pathogens alike. These events can also dictate the nature of
immune cell death, which has been reported to occur via two
types of programmed necrosis, namely necroptosis or pyroptosis.
Necroptosis is induced by the interaction of TNF with receptorinteracting protein kinase 1 (RIPK1), eliciting a cascade that
culminates in the phosphorylation of mixed lineage kinase
domain-like protein (MLKL) that damages the plasma
membrane leading to cell death. Pyroptosis occurs in response
to inﬂammasome activation that cleaves gasdermin D, which
oligomerizes to form pores in the cell membrane. While both
forms of cell death induce inﬂammation, the heightened
production of inﬂammatory mediators associated with
inﬂammasome activation makes pyroptosis more inﬂammatory
in nature than necroptosis (114). The roles of S. aureus
metabolism in dictating different modes of immune cell death
will be discussed below.

CARBOHYDRATE AVAILABILITY AND S.
AUREUS METABOLISM
Much work has been done to elucidate S. aureus metabolic
adaptations under a variety of in vitro and in vivo conditions
and the reader is directed to several excellent and comprehensive
reviews on the topic (9, 23, 24), since only a brief overview is
provided here. S. aureus utilizes a number of two-component
regulatory systems to sense changes in its environment (115,
116). These systems interface with complex transcriptional
networks to tightly control nutrient use throughout different
phases of growth and infection. This is referred to as carbon
catabolite repression and ensures that bacteria optimally utilize
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HYPOXIA AND S. AUREUS METABOLISM
Hypoxia is particularly relevant in the context of bioﬁlm
infections, since bacteria in the innermost regions of the bioﬁlm
experience low oxygen bioavailability. Anaerobic conditions have
been shown to induce the expression of bioﬁlm-associated genes
such as icaADBC that encode polysaccharide intercellular
adhesins that promote bacterial aggregation and adherence to
host surfaces (134–136). Bone, a niche that is often targeted by
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EPIGENETIC CHANGES INDUCED BY
IMMUNOMODULATORY METABOLITES

S. aureus bioﬁlm, has a low oxygen tension since it is less
vascularized compared to other tissues (137, 138). The immune
response elicited during S. aureus bone infection exacerbates this
hypoxic environment as inﬁltrating immune cells quickly increase
their oxygen demand upon activation (139, 140). The bioﬁlm
responds to this progressive decline in oxygen tension by
switching from respiration to fermentation concomitant with an
increase in virulence factor production to attack immune cells to
promote infection persistence (141). The transition from
respiration to fermentation in S. aureus is regulated by several
factors including SrrAB and Rex. The SrrAB two-component
system was initially identiﬁed through homology comparisons
with the ResDE two-component system of Bacillus subtilis, which
controls the switch between aerobic and anaerobic respiration
(142). While its ligand remains unknown, SrrAB increases the
expression of fermentative genes such as pﬂAB, adhE, and nrdDG
that allow it to thrive in an anaerobic environment (141, 143, 144).
S. aureus can also respond to changes in oxygen availability
indirectly through the transcriptional repressor Rex, which
inhibits genes that are important for anaerobic respiration when
oxygen is present. Rex senses redox conditions within the cell
through changes in the NADH/NAD+ pools. As NADH levels
rise, Rex becomes derepressed and is released from the DNA,
thereby allowing for the transcription of fermentative genes in an
effort to maintain reducing equivalents within the cell (9, 145).
Therefore, oxygen depletion could either be a consequence of
bacterial growth, or a strategy enacted by the bioﬁlm to ensure
persistent infection.

Bacterial-derived metabolites are also capable of affecting
leukocyte activation and function. Recent work has shown that
lactate production by S. aureus bioﬁlm induces epigenetic
changes in leukocytes at the level of histone acetylation (146).
Utilizing a number of S. aureus lactate dehydrogenase (ldh)
mutants, our group demonstrated that bioﬁlm-derived lactate
was imported into MDSCs and macrophages where it inhibited
histone deacetylase 11 (HDAC11; Figure 3). HDAC11 inhibition
prevented its normal function of counterbalancing HDAC6
activity that is a positive regulator of IL-10 transcription,
resulting in enhanced IL-10 production and bioﬁlm
persistence. Synovial ﬂuid from patients with PJI contained
elevated amounts of both D-lactate and IL-10 compared with
control subjects and IL-10 production by human monocytederived macrophages was induced by bioﬁlm-derived lactate,
supporting the translational relevance of these ﬁndings (146).
This demonstrates how a bacterial-derived metabolite can
signiﬁcantly rewire the host-pathogen dynamic to favor
persistent infection. Recently, lactate has also been shown to
directly modify histones with functional genomic implications
(147–149). This lactate modiﬁcation of histone lysine residues
(termed lactylation) was shown to operate as a sort of “clock”. As
inﬂammation progressed, the lactate produced by increased
glycolysis lactylated histones. As these lactate marks
accumulated, homeostatic genes were induced that led to a

FIGURE 3 | S. aureus bioﬁlm regulates leukocyte inﬂammatory activity. S. aureus bioﬁlms employ a number of strategies to create an infection milieu to ensure
persistence. Two of these approaches involve the action of either bacterial-derived metabolites or intrinsic reprogramming of monocyte/macrophage metabolism that
culminate in the expression of anti-inﬂammatory genes. (Top) Bioﬁlm augments oxidative metabolism in inﬁltrating monocytes and macrophages that biases them
towards an anti-inﬂammatory phenotype. (Bottom) In MDSCs and macrophages, bioﬁlm-derived lactate causes epigenomic remodeling that leads to an increase in
IL-10 expression. Figure created with BioRender.
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the primary infection. The reduction in fumarate by SCVs increased
host cell glycolysis, which inhibited trained immunity by
necroptosis (Figure 4) rather than inﬂammasome-dependent
pyroptosis (165). This is beneﬁcial for bacterial persistence since
necroptosis elicits less inﬂammation compared to pyroptosis (166).
These effects were not observed with wild type S. aureus, which was
less effective at utilizing fumarate. This difference may represent one
explanation for why S. aureus SCVs are typically associated with
chronic infections.

resolution of inﬂammation. Thus, histone lactylation functions
as an endogenous timer for inﬂammatory events.
While innate immune cells do not possess the characteristic
long-lasting immunity of lymphocytes, they are capable of trained
immune memory (150, 151). Trained immunity arises from
epigenetic modiﬁcations that prime leukocytes for a subsequent
encounter with another stimulus (152–154). Interestingly, trained
immunity is not stimulus-speciﬁc and can induce widespread
changes in how a leukocyte responds to a second insult. Several
studies have shown that prior infection with S. aureus establishes
trained immunity in macrophages that provides temporary
protection from a second bacterial challenge (155–157). Trained
immunity in response to S. aureus has been shown to occur via
epigenetic changes induced by the metabolite fumarate. Fumarate,
like lactate, interferes with the epigenomic remodeling of histone
marks by acting as an antagonist for lysine demethylases (KDMs)
(158–162). A recent study demonstrated the importance of fumarate
during S. aureus infection by contrasting wild type infection with
DhemB small colony variants (SCVs) that were able to deplete local
fumarate stores via enhanced fumarate hydratase (fumC) expression
(163, 164). Trained immunity was assessed by comparing bacterial
burden after a secondary challenge with S. aureus 28 days following

MODULATING METABOLISM AS A
THERAPEUTIC TARGET
The selective targeting of either host or pathogen metabolism
represents an exciting therapeutic prospect that would bolster
traditional antibiotic therapies that are commonly used for
infections. Metabolic interventions have the potential to be
highly efﬁcacious as was shown in our work where metabolically
reprogramming monocytes synergized with antibiotics to reduce
established S. aureus bioﬁlm infection to below the limit of
detection (81). Of particular interest are therapies targeting

FIGURE 4 | S. aureus small colony variants (SCVs) interfere with the establishment of trained immunity. The generation of SCVs with mutations in metabolic
pathways exert inﬂuence over the formation of trained immunity. S. aureus SCVs with hyperactive fumarate hydratase (fumC) quickly degrade mitochondrial pools of
fumarate, which leads to an upregulation of glycolysis and impaired formation of trained immunity. The absence of fumuarate causes KDM5 to become active, which
removes the methylation marks around the promoters of pro-inﬂammatory genes, thereby decreasing the accessilibity of the chromatin in these regions. Figure
created with BioRender.
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metabolism, but also that of the host. Further work is needed
to understand the numerous intricacies that underpin
metabolism, especially in the context of an infection where
multiple players are involved. Fortunately, the ﬁeld is
advancing rapidly with the development of novel tools and
methods to dissect metabolism with single cell resolution (168,
169). The continued development of these technologies will be
integral for future studies. Should these efforts be successful,
metabolic modulation could advance therapeutic approaches for
S. aureus infection in combination with conventional antibiotic
treatment regimens.

immunometabolism rather than bacterial metabolism, since
pathogen resistance would be less prevalent with a host-targeted
approach. If we can gain a better understanding of the underlying
metabolic modules that dictate beneﬁcial vs. detrimental immune
responses, then it should be feasible to tailor leukocyte metabolism
to enhance pathogen neutralization. The main caveat of this
approach is that the metabolic pathways utilized by the host and
pathogens share many attributes. Therefore, potential metabolic
therapies would need to be targeted to avoid non-speciﬁc effects.

CONCLUSION AND FUTURE DIRECTIONS
In a time of increasing interest in leukocyte metabolism, it is
important to think globally in terms of the interplay between
host and pathogen metabolic states. Bacterial pathogens, such as
S. aureus, undergo their own metabolic programming (10, 11),
often in direct competition with responding immune cells. In
addition, the metabolic attributes of tissue resident parenchymal
cells have the potential to shape the metabolic responses of both
inﬁltrating leukocytes and bacteria, revealing another level of
complexity. Considerable care must be taken when designing
experiments to deconstruct these complex systems in vitro, since
the composition of mammalian cell culture media can have
drastic deviations from metabolite concentrations found in
human plasma (167). Therefore, ﬁndings must be validated
in leukocytes and bacteria immediately ex vivo, as the selection
of in vitro culture conditions could result in metabolic changes
that are not reﬂective of in vivo infection (167).
As discussed in this review, S. aureus as well as other bacterial
pathogens possess the ability to not only modify their

AUTHOR CONTRIBUTIONS
CH wrote the manuscript draft that was edited by TK and CH.
All authors contributed to the article and approved the
submitted version.

FUNDING
The Kielian laboratory is supported by NIH grants R01
NS107369 and 3P01AI083211 (Project 4 to TK).

ACKNOWLEDGMENTS
We apologize to authors whose work could not be cited due to
space constraints.

REFERENCES

10. Potter AD, Butrico CE, Ford CA, Curry JM, Trenary IA, Tummarakota SS,
et al. Host nutrient milieu drives an essential role for aspartate biosynthesis
during invasive Staphylococcus aureus infection. Proc Natl Acad Sci USA
(2020) 117(22):12394–401.
11. Lehman MK, Nuxoll AS, Yamada KJ, Kielian T, Carson SD, Fey PD.
Protease-Mediated Growth of Staphylococcus aureus on Host Proteins Is
opp3 Dependent. mBio (2019) 10(2):e02553–18.
12. Riquelme SA, Wong Fok Lung T, Prince A. Pulmonary Pathogens Adapt
to Immune Signaling Metabolites in the Airway. Front Immunol (2020)
11:385.
13. Mazharul Islam M, Thomas VC, Van Beek M, Ahn JS, Alqarzaee AA, Zhou C,
et al. An integrated computational and experimental study to investigate
Staphylococcus aureus metabolism. NPJ Syst Biol Appl (2020) 6(1):3.
14. Mathis D, Shoelson SE. Immunometabolism: an emerging frontier. Nat Rev
Immunol (2011) 11(2):81.
15. O’Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for
immunologists. Nat Rev Immunol (2016) 16(9):553–65.
16. Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and
quiescence. Immunity (2013) 38(4):633–43.
17. Galvan-Pena S, O’Neill LA. Metabolic reprograming in macrophage
polarization. Front Immunol (2014) 5:420.
18. Infantino V, Convertini P, Cucci L, Panaro MA, Di Noia MA, Calvello R,
et al. The mitochondrial citrate carrier: a new player in inﬂammation.
Biochem J (2011) 438(3):433–6.
19. Ricciotti E, FitzGerald GA. Prostaglandins and inﬂammation. Arterioscler
Thromb Vasc Biol (2011) 31(5):986–1000.
20. O’Neill LA. A critical role for citrate metabolism in LPS signalling. Biochem J
(2011) 438(3):e5–6.

1. Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A,
et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers (2018)
4:18033.
2. Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah
PP, Carugati M, et al. Methicillin-resistant Staphylococcus aureus: an
overview of basic and clinical research. Nat Rev Microbiol (2019) 17
(4):203–18.
3. Schilcher K, Horswill AR. Staphylococcal Bioﬁlm Development: Structure,
Regulation, and Treatment Strategies. Microbiol Mol Biol Rev (2020) 84(3):
e00026–19.
4. Tam K, Torres VJ. Staphylococcus aureus Secreted Toxins and Extracellular
Enzymes. Microbiol Spectr (2019) 7(2). doi: 10.1128/microbiolspec.GPP30039-2018
5. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol (2005) 3
(12):948–58.
6. Askarian F, Wagner T, Johannessen M, Nizet V. Staphylococcus aureus
modulation of innate immune responses through Toll-like (TLR), (NOD)like (NLR) and C-type lectin (CLR) receptors. FEMS Microbiol Rev (2018)
42(5):656–71.
7. Olive AJ, Sassetti CM. Metabolic crosstalk between host and pathogen:
sensing, adapting and competing. Nat Rev Microbiol (2016) 14(4):221–34.
8. Ayres JS. Immunometabolism of infections. Nat Rev Immunol (2020) 20
(2):79–80.
9. Somerville GA, Proctor RA. At the crossroads of bacterial metabolism and
virulence factor synthesis in Staphylococci. Microbiol Mol Biol Rev (2009) 73
(2):233–48.

Frontiers in Immunology | www.frontiersin.org

9

February 2021 | Volume 11 | Article 621750

Horn and Kielian

Host-Pathogen Metabolic Crosstalk

42. Mills EL, Kelly B, Logan A, Costa ASH, Varma M, Bryant CE, et al. Succinate
Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive
Inﬂammatory Macrophages. Cell (2016) 167(2):457–70.
43. Wang D, Malo D, Hekimi S. Elevated mitochondrial reactive oxygen species
generation affects the immune response via hypoxia-inducible factor-1alpha
in long-lived Mclk1+/- mouse mutants. J Immunol (2010) 184(2):582–90.
44. Benit P, Letouze E, Rak M, Aubry L, Burnichon N, Favier J, et al.
Unsuspected task for an old team: succinate, fumarate and other Krebs
cycle acids in metabolic remodeling. Biochim Biophys Acta (2014) 1837
(8):1330–7.
45. Swanson KV, Deng M, Ting JP. The NLRP3 inﬂammasome: molecular
activation and regulation to therapeutics. Nat Rev Immunol (2019) 19
(8):477–89.
46. Hughes MM, O’Neill LAJ. Metabolic regulation of NLRP3. Immunol Rev
(2018) 281(1):88–98.
47. Haneklaus M, O’Neill LA. NLRP3 at the interface of metabolism and
inﬂammation. Immunol Rev (2015) 265(1):53–62.
48. McGettrick AF, O’Neill LAJ. The Role of HIF in Immunity and
Inﬂammation. Cell Metab (2020) 32(4):524–36.
49. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N,
et al. HIF-1alpha is essential for myeloid cell-mediated inﬂammation. Cell
(2003) 112(5):645–57.
50. Craven RR, Gao X, Allen IC, Gris D, Bubeck Wardenburg J, McElvaniaTekippe E, et al. Staphylococcus aureus alpha-hemolysin activates the
NLRP3-inﬂammasome in human and mouse monocytic cells. PloS One
(2009) 4(10):e7446.
51. Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inﬂammasomeactivated gasdermin D causes pyroptosis by forming membrane pores.
Nature (2016) 535(7610):153–8.
52. Munoz-Planillo R, Franchi L, Miller LS, Nunez G. A critical role for
hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced
activation of the Nlrp3 inﬂammasome. J Immunol (2009) 183(6):3942–8.
53. Wang X, Eagen WJ, Lee JC. Orchestration of human macrophage NLRP3
inﬂammasome activation by Staphylococcus aureus extracellular vesicles.
Proc Natl Acad Sci U S A (2020) 117(6):3174–84.
54. Cohen TS, Boland ML, Boland BB, Takahashi V, Tovchigrechko A, Lee Y,
et al. S. aureus Evades Macrophage Killing through NLRP3-Dependent
Effects on Mitochondrial Trafﬁcking. Cell Rep (2018) 22(9):2431–41.
55. Michelucci A, Cordes T, Ghelﬁ J, Pailot A, Reiling N, Goldmann O, et al.
Immune-responsive gene 1 protein links metabolism to immunity by catalyzing
itaconic acid production. Proc Natl Acad Sci USA (2013) 110(19):7820–5.
56. Degrandi D, Hoffmann R, Beuter-Gunia C, Pfeffer K. The proinﬂammatory
cytokine-induced IRG1 protein associates with mitochondria. J Interferon
Cytokine Res (2009) 29(1):55–67.
57. Ackermann WW, Potter VR. Enzyme inhibition in relation to
chemotherapy. Proc Soc Exp Biol Med (1949) 72(1):1–9.
58. Nemeth B, Doczi J, Csete D, Kacso G, Ravasz D, Adams D, et al. Abolition of
mitochondrial substrate-level phosphorylation by itaconic acid produced by
LPS-induced Irg1 expression in cells of murine macrophage lineage. FASEB J
(2016) 30(1):286–300.
59. Tomlinson K, Dach F, Riquelme SA, Wong T, Moustafa AM, Planet PJ, et al.
In Vivo Adaptation of S. Aureus to the Lung Is Driven by Itaconate, A
Mitochondrial Immune Metabolite. Am J Respiratory Crit Care Med (2020)
doi: 10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A7715
60. O’Neill LAJ, Artyomov MN. Itaconate: the poster child of metabolic
reprogramming in macrophage function. Nat Rev Immunol (2019) 19
(5):273–81.
61. Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, et al.
Itaconate is an anti-inﬂammatory metabolite that activates Nrf2 via
alkylation of KEAP1. Nature (2018) 556(7699):113–7.
62. Bambouskova M, Gorvel L, Lampropoulou V, Sergushichev A, Loginicheva
E, Johnson K, et al. Electrophilic properties of itaconate and derivatives
regulate the IkappaBzeta-ATF3 inﬂammatory axis. Nature (2018) 556
(7702):501–4.
63. Saito R, Suzuki T, Hiramoto K, Asami S, Naganuma E, Suda H, et al.
Characterizations of Three Major Cysteine Sensors of Keap1 in Stress
Response. Mol Cell Biol (2016) 36(2):271–84.

21. Traven A, Naderer T. Central metabolic interactions of immune cells and
microbes: prospects for defeating infections. EMBO Rep (2019) 20(7):
e47995.
22. Tuchscherr L, Lofﬂer B, Proctor RA. Persistence of Staphylococcus aureus:
Multiple Metabolic Pathways Impact the Expression of Virulence Factors in
Small-Colony Variants (SCVs). Front Microbiol (2020) 11:1028.
23. Richardson AR. Virulence and Metabolism. Microbiol Spectr (2019) 7(2) doi:
10.1128/microbiolspec.GPP3-0011-2018
24. Balasubramanian D, Harper L, Shopsin B, Torres VJ. Staphylococcus aureus
pathogenesis in diverse host environments. Pathog Dis (2017) 75(1). doi:
10.1093/femspd/ftx005
25. Heim CE, Vidlak D, Kielian T. Interleukin-10 production by myeloidderived suppressor cells contributes to bacterial persistence during
Staphylococcus aureus orthopedic bioﬁlm infection. J Leukoc Biol (2015)
98(6):1003–13.
26. Heim CE, Vidlak D, Scherr TD, Hartman CW, Garvin KL, Kielian T. IL-12
promotes myeloid-derived suppressor cell recruitment and bacterial
persistence during Staphylococcus aureus orthopedic implant infection.
J Immunol (2015) 194(8):3861–72.
27. Heim CE, Vidlak D, Scherr TD, Kozel JA, Holzapfel M, Muirhead DE, et al.
Myeloid-derived suppressor cells contribute to Staphylococcus aureus
orthopedic bioﬁlm infection. J Immunol (2014) 192(8):3778–92.
28. Heim CE, West SC, Ali H, Kielian T. Heterogeneity of Ly6G(+) Ly6C(+)
Myeloid-Derived Suppressor Cell Inﬁltrates during Staphylococcus aureus
Bioﬁlm Infection. Infect Immun (2018) 86(12):e00684–18.
29. Bosch ME, Bertrand BP, Heim CE, Alqarzaee AA, Chaudhari SS, Aldrich
AL, et al. Staphylococcus aureus ATP Synthase Promotes Bioﬁlm Persistence
by Inﬂuencing Innate Immunity. mBio (2020) 11(5):e01581–20.
30. Grosser MR, Paluscio E, Thurlow LR, Dillon MM, Cooper VS, Kawula TH,
et al. Genetic requirements for Staphylococcus aureus nitric oxide resistance
and virulence. PloS Pathog (2018) 14(3):e1006907.
31. Gabryszewski SJ, Wong Fok Lung T, Annavajhala MK, Tomlinson KL,
Riquelme SA, Khan IN, et al. Metabolic Adaptation in Methicillin-Resistant
Staphylococcus aureus Pneumonia. Am J Respir Cell Mol Biol (2019) 61
(2):185–97.
32. Newsholme P, Gordon S, Newsholme EA. Rates of utilization and fates of
glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse
macrophages. Biochem J (1987) 242(3):631–6.
33. Freemerman AJ, Johnson AR, Sacks GN, Milner JJ, Kirk EL, Troester MA,
et al. Metabolic reprogramming of macrophages: glucose transporter 1
(GLUT1)-mediated glucose metabolism drives a proinﬂammatory
phenotype. J Biol Chem (2014) 289(11):7884–96.
34. Fukuzumi M, Shinomiya H, Shimizu Y, Ohishi K, Utsumi S. Endotoxininduced enhancement of glucose inﬂux into murine peritoneal macrophages
via GLUT1. Infect Immun (1996) 64(1):108–12.
35. Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y,
Loginicheva E, et al. Network integration of parallel metabolic and
transcriptional data reveals metabolic modules that regulate macrophage
polarization. Immunity (2015) 42(3):419–30.
36. Rodriguez-Prados JC, Traves PG, Cuenca J, Rico D, Aragones J, MartinSanz P, et al. Substrate fate in activated macrophages: a comparison
between innate, classic, and alternative activation. J Immunol (2010) 185
(1):605–14.
37. Kelly B, O’Neill LA. Metabolic reprogramming in macrophages and
dendritic cells in innate immunity. Cell Res (2015) 25(7):771–84.
38. Ryan DG, Murphy MP, Frezza C, Prag HA, Chouchani ET, O’Neill LA, et al.
Coupling Krebs cycle metabolites to signalling in immunity and cancer. Nat
Metab (2019) 1:16–33.
39. Lachmandas E, Boutens L, Ratter JM, Hijmans A, Hooiveld GJ, Joosten LA,
et al. Microbial stimulation of different Toll-like receptor signalling pathways
induces diverse metabolic programmes in human monocytes. Nat Microbiol
(2016) 2:16246.
40. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick
AF, Goel G, et al. Succinate is an inﬂammatory signal that induces IL-1beta
through HIF-1alpha. Nature (2013) 496(7444):238–42.
41. Mills E, O’Neill LA. Succinate: a metabolic signal in inﬂammation. Trends
Cell Biol (2014) 24(5):313–20.

Frontiers in Immunology | www.frontiersin.org

10

February 2021 | Volume 11 | Article 621750

Horn and Kielian

Host-Pathogen Metabolic Crosstalk

89. Palsson-McDermott EM, O’Neill LAJ. Targeting immunometabolism as an
anti-inﬂammatory strategy. Cell Res (2020) 30(4):300–14.
90. Howard NC, Khader SA. Immunometabolism during Mycobacterium
tuberculosis Infection. Trends Microbiol (2020) 28(10):832–50.
91. O’Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and
macrophage function. J Exp Med (2016) 213(1):15–23.
92. Kumar R, Singh P, Kolloli A, Shi L, Bushkin Y, Tyagi S, et al.
Immunometabolism of Phagocytes During Mycobacterium tuberculosis
Infection. Front Mol Biosci (2019) 6:105.
93. Rice CM, Davies LC, Subleski JJ, Maio N, Gonzalez-Cotto M, Andrews C,
et al. Tumour-elicited neutrophils engage mitochondrial metabolism to
circumvent nutrient limitations and maintain immune suppression. Nat
Commun (2018) 9(1):5099.
94. Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E, et al.
Mechanism regulating reactive oxygen species in tumor-induced myeloidderived suppressor cells. J Immunol (2009) 182(9):5693–701.
95. Chen X, Song M, Zhang B, Zhang Y. Reactive Oxygen Species Regulate T
Cell Immune Response in the Tumor Microenvironment. Oxid Med Cell
Longev (2016) 2016:1580967.
96. Zhang H, Li ZL, Ye SB, Ouyang LY, Chen YS, He J, et al. Myeloid-derived
suppressor cells inhibit T cell proliferation in human extranodal NK/T cell
lymphoma: a novel prognostic indicator. Cancer Immunol Immunother
(2015) 64(12):1587–99.
97. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of
the immune system. Nat Rev Immunol (2009) 9(3):162–74.
98. Ostrand-Rosenberg S, Fenselau C. Myeloid-Derived Suppressor Cells:
Immune-Suppressive Cells That Impair Antitumor Immunity and Are
Sculpted by Their Environment. J Immunol (2018) 200(2):422–31.
99. Mastio J, Condamine T, Dominguez G, Kossenkov AV, Donthireddy L,
Veglia F, et al. Identiﬁcation of monocyte-like precursors of granulocytes in
cancer as a mechanism for accumulation of PMN-MDSCs. J Exp Med (2019)
216(9):2150–69.
100. Ohl K, Tenbrock K. Reactive Oxygen Species as Regulators of MDSCMediated Immune Suppression. Front Immunol (2018) 9:2499.
101. Aarts CEM, Hiemstra IH, Beguin EP, Hoogendijk AJ, Bouchmal S, van
Houdt M, et al. Activated neutrophils exert myeloid-derived suppressor cell
activity damaging T cells beyond repair. Blood Adv (2019) 3(22):3562–74.
102. Tebartz C, Horst SA, Sparwasser T, Huehn J, Beineke A, Peters G, et al. A
major role for myeloid-derived suppressor cells and a minor role for
regulatory T cells in immunosuppression during Staphylococcus aureus
infection. J Immunol (2015) 194(3):1100–11.
103. Skabytska Y, Wolbing F, Gunther C, Koberle M, Kaesler S, Chen KM, et al.
Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands
suppresses T cell immunity by inducing myeloid-derived suppressor cells.
Immunity (2014) 41(5):762–75.
104. Wang Y, Jia A, Bi Y, Wang Y, Liu G. Metabolic Regulation of MyeloidDerived Suppressor Cell Function in Cancer. Cells (2020) 9(4). doi: 10.3390/
cells9041011
105. Sica A, Strauss L. Energy metabolism drives myeloid-derived suppressor cell
differentiation and functions in pathology. J Leukoc Biol (2017) 102(2):325–
34.
106. Yan D, Adeshakin AO, Xu M, Afolabi LO, Zhang G, Chen YH, et al. Lipid
Metabolic Pathways Confer the Immunosuppressive Function of MyeloidDerived Suppressor Cells in Tumor. Front Immunol (2019) 10:1399.
107. Baumann T, Dunkel A, Schmid C, Schmitt S, Hiltensperger M, Lohr K, et al.
Regulatory myeloid cells paralyze T cells through cell-cell transfer of the
metabolite methylglyoxal. Nat Immunol (2020) 21(5):555–66.
108. Ramesh V, Locasale JW. A reactive metabolite as an immune suppressant.
Nat Immunol (2020) 21(5):497–8.
109. Veglia F, Tyurin VA, Blasi M, De Leo A, Kossenkov AV, Donthireddy L,
et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature
(2019) 569(7754):73–8.
110. Riquelme SA, Liimatta K, Wong Fok Lung T, Fields B, Ahn D, Chen D, et al.
Pseudomonas aeruginosa Utilizes Host-Derived Itaconate to Redirect Its
Metabolism to Promote Bioﬁlm Formation. Cell Metab (2020) 31(6):1091–
106 e6.
111. Fischer AJ, Singh SB, LaMarche MM, Maakestad LJ, Kienenberger ZE, Pena
TA, et al. Sustained Coinfections with Staphylococcus aureus and

64. Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M,
Sekine H, et al. Nrf2 suppresses macrophage inﬂammatory response
by blocking proinﬂammatory cytokine transcription. Nat Commun
(2016) 7:11624.
65. Luan HH, Medzhitov R. Food Fight: Role of Itaconate and Other Metabolites
in Antimicrobial Defense. Cell Metab (2016) 24(3):379–87.
66. Cordes T, Wallace M, Michelucci A, Divakaruni AS, Sapcariu SC, Sousa C,
et al. Immunoresponsive Gene 1 and Itaconate Inhibit Succinate
Dehydrogenase to Modulate Intracellular Succinate Levels. J Biol Chem
(2016) 291(27):14274–84.
67. Rath M, Muller I, Kropf P, Closs EI, Munder M. Metabolism via Arginase or
Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages.
Front Immunol (2014) 5:532.
68. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function.
Annu Rev Immunol (1997) 15:323–50.
69. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and
controversies. Nat Rev Microbiol (2004) 2(10):820–32.
70. Nathan CF, Hibbs JBJr. Role of nitric oxide synthesis in macrophage
antimicrobial activity. Curr Opin Immunol (1991) 3(1):65–70.
71. Sasaki S, Miura T, Nishikawa S, Yamada K, Hirasue M, Nakane A. Protective
role of nitric oxide in Staphylococcus aureus infection in mice. Infect Immun
(1998) 66(3):1017–22.
72. Richardson AR, Dunman PM, Fang FC. The nitrosative stress response of
Staphylococcus aureus is required for resistance to innate immunity. Mol
Microbiol (2006) 61(4):927–39.
73. Richardson AR, Libby SJ, Fang FC. A nitric oxide-inducible lactate
dehydrogenase enables Staphylococcus aureus to resist innate immunity.
Science (2008) 319(5870):1672–6.
74. Albina JE, Mills CD, Barbul A, Thirkill CE, Henry WLJr., Mastrofrancesco B,
et al. Arginine metabolism in wounds. Am J Physiol (1988) 254(4 Pt 1):E459–
67.
75. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas.
J Clin Invest (2012) 122(3):787–95.
76. Hanke ML, Heim CE, Angle A, Sanderson SD, Kielian T. Targeting
macrophage activation for the prevention and treatment of
Staphylococcus aureus bioﬁlm infections. J Immunol (2013) 190(5):2159–68.
77. Hanke ML, Angle A, Kielian T. MyD88-dependent signaling inﬂuences
ﬁbrosis and alternative macrophage activation during Staphylococcus aureus
bioﬁlm infection. PloS One (2012) 7(8):e42476.
78. Heim CE, Hanke ML, Kielian T. A mouse model of Staphylococcus catheterassociated bioﬁlm infection. Methods Mol Biol (2014) 1106:183–91.
79. Yamada KJ, Heim CE, Aldrich AL, Gries CM, Staudacher AG, Kielian T.
Arginase-1 Expression in Myeloid Cells Regulates Staphylococcus aureus
Planktonic but Not Bioﬁlm Infection. Infect Immun (2018) 86(7):e00206–18.
80. Thurlow LR, Joshi GS, Clark JR, Spontak JS, Neely CJ, Maile R, et al.
Functional modularity of the arginine catabolic mobile element contributes
to the success of USA300 methicillin-resistant Staphylococcus aureus. Cell
Host Microbe (2013) 13(1):100–7.
81. Yamada KJ, Heim CE, Xi X, Attri KS, Wang D, Zhang W, et al. Monocyte
metabolic reprogramming promotes pro-inﬂammatory activity and
Staphylococcus aureus bioﬁlm clearance. PloS Pathog (2020) 16(3):
e1008354.
82. Thurlow LR, Hanke ML, Fritz T, Angle A, Aldrich A, Williams SH, et al.
Staphylococcus aureus bioﬁlms prevent macrophage phagocytosis and
attenuate inﬂammation in vivo. J Immunol (2011) 186(11):6585–96.
83. Kominsky DJ, Campbell EL, Colgan SP. Metabolic shifts in immunity and
inﬂammation. J Immunol (2010) 184(8):4062–8.
84. Sbarra AJ, Karnovsky ML. The biochemical basis of phagocytosis. I.
Metabolic changes during the ingestion of particles by polymorphonuclear
leukocytes. J Biol Chem (1959) 234(6):1355–62.
85. Warburg O, Wind F, Negelein E. The Metabolism of Tumors in the Body.
J Gen Physiol (1927) 8(6):519–30.
86. DeBerardinis RJ, Chandel NS. We need to talk about the Warburg effect. Nat
Metab (2020) 2(2):127–9.
87. Borregaard N, Herlin T. Energy metabolism of human neutrophils during
phagocytosis. J Clin Invest (1982) 70(3):550–7.
88. Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes.
Blood (2008) 112(4):935–45.

Frontiers in Immunology | www.frontiersin.org

11

February 2021 | Volume 11 | Article 621750

Horn and Kielian

112.

113.

114.
115.

116.

117.
118.
119.
120.
121.

122.

123.

124.

125.

126.

127.

128.

129.

130.

131.

132.

133.

Host-Pathogen Metabolic Crosstalk

Pseudomonas aeruginosa in Cystic Fibrosis. Am J Respir Crit Care Med
(2020). doi: 10.1164/rccm.202004-1322OC
Bernardy EE, Petit R, Raghuram V, Alexander AM, Read TD, Goldberg
JB. Genotypic and Phenotypic Diversity of Staphylococcus aureus
Isolates from Cystic Fibrosis Patient Lung Infections and Their
Interactions with Pseudomonas aeruginosa. mBio (2020) 11(3):e00735–
20.
Limoli DH, Hoffman LR. Help, hinder, hide and harm: what can we learn
from the interactions between Pseudomonas aeruginosa and Staphylococcus
aureus during respiratory infections? Thorax (2019) 74(7):684–92.
Nagata S, Tanaka M. Programmed cell death and the immune system. Nat
Rev Immunol (2017) 17(5):333–40.
Rapun-Araiz B, Haag AF, De Cesare V, Gil C, Dorado-Morales P, Penades
JR, et al. Systematic Reconstruction of the Complete Two-Component
Sensorial Network in Staphylococcus aureus. mSystems (2020) 5(4):
e00511–20.
Bronner S, Monteil H, Prevost G. Regulation of virulence determinants in
Staphylococcus aureus: complexity and applications. FEMS Microbiol Rev
(2004) 28(2):183–200.
Titgemeyer F, Hillen W. Global control of sugar metabolism: a gram-positive
solution. Antonie Van Leeuwenhoek (2002) 82(1-4):59–71.
Gorke B, Stulke J. Carbon catabolite repression in bacteria: many ways to
make the most out of nutrients. Nat Rev Microbiol (2008) 6(8):613–24.
Warner JB, Lolkema JS. CcpA-dependent carbon catabolite repression in
bacteria. Microbiol Mol Biol Rev (2003) 67(4):475–90.
Strasters KC, Winkler KC. Carbohydrate Metabolism of Staphylococcus
Aureus. J Gen Microbiol (1963) 33:213–29.
Seidl K, Goerke C, Wolz C, Mack D, Berger-Bachi B, Bischoff M.
Staphylococcus aureus CcpA affects bioﬁlm formation. Infect Immun
(2008) 76(5):2044–50.
Seidl K, Muller S, Francois P, Kriebitzsch C, Schrenzel J, Engelmann S, et al.
Effect of a glucose impulse on the CcpA regulon in Staphylococcus aureus.
BMC Microbiol (2009) 9:95.
Hartmann T, Zhang B, Baronian G, Schulthess B, Homerova D, Grubmuller
S, et al. Catabolite control protein E (CcpE) is a LysR-type transcriptional
regulator of tricarboxylic acid cycle activity in Staphylococcus aureus. J Biol
Chem (2013) 288(50):36116–28.
Ding Y, Liu X, Chen F, Di H, Xu B, Zhou L, et al. Metabolic sensor governing
bacterial virulence in Staphylococcus aureus. Proc Natl Acad Sci USA (2014)
111(46):E4981–90.
Wickersham M, Wachtel S, Wong Fok Lung T, Soong G, Jacquet R,
Richardson A, et al. Metabolic Stress Drives Keratinocyte Defenses against
Staphylococcus aureus Infection. Cell Rep (2017) 18(11):2742–51.
Prince A, Wong Fok Lung T. Consequences of Metabolic Interactions during
Staphylococcus aureus Infection. Toxins (Basel) (2020) 12(9):581. doi:
10.3390/toxins12090581
Smit J, Sogaard M, Schonheyder HC, Nielsen H, Froslev T, Thomsen RW.
Diabetes and risk of community-acquired Staphylococcus aureus
bacteremia: a population-based case-control study. Eur J Endocrinol
(2016) 174(5):631–9.
Lipsky BA, Tabak YP, Johannes RS, Vo L, Hyde L, Weigelt JA. Skin and soft
tissue infections in hospitalised patients with diabetes: culture isolates and
risk factors associated with mortality, length of stay and cost. Diabetologia
(2010) 53(5):914–23.
Thurlow LR, Stephens AC, Hurley KE, Richardson AR. Lack of nutritional
immunity in diabetic skin infections promotes &lt;em<Staphylococcus
aureus&lt;/em< virulence. Sci Adv (2020) 6(46):eabc5569.
Cohen TS, Takahashi V, Bonnell J, Tovchigrechko A, Chaerkady R, Yu W,
et al. Staphylococcus aureus drives expansion of low-density neutrophils in
diabetic mice. J Clin Invest (2019) 129(5):2133–44.
Wong SL, Demers M, Martinod K, Gallant M, Wang Y, Goldﬁne AB, et al.
Diabetes primes neutrophils to undergo NETosis, which impairs wound
healing. Nat Med (2015) 21(7):815–9.
Sagiv JY, Michaeli J, Assi S, Mishalian I, Kisos H, Levy L, et al. Phenotypic
diversity and plasticity in circulating neutrophil subpopulations in cancer.
Cell Rep (2015) 10(4):562–73.
Brandau S, Trellakis S, Bruderek K, Schmaltz D, Steller G, Elian M, et al.
Myeloid-derived suppressor cells in the peripheral blood of cancer patients

Frontiers in Immunology | www.frontiersin.org

134.

135.

136.

137.

138.

139.
140.
141.

142.

143.

144.

145.

146.

147.

148.
149.
150.

151.
152.

153.
154.

155.

156.

12

contain a subset of immature neutrophils with impaired migratory
properties. J Leukoc Biol (2011) 89(2):311–7.
Cramton SE, Ulrich M, Gotz F, Doring G. Anaerobic conditions induce
expression of polysaccharide intercellular adhesin in Staphylococcus aureus
and Staphylococcus epidermidis. Infect Immun (2001) 69(6):4079–85.
Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, DeLeo FR, et al. A crucial
role for exopolysaccharide modiﬁcation in bacterial bioﬁlm formation, immune
evasion, and virulence. J Biol Chem (2004) 279(52):54881–6.
O’Gara JP. ica and beyond: bioﬁlm mechanisms and regulation in
Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol
Lett (2007) 270(2):179–88.
Spencer JA, Ferraro F, Roussakis E, Klein A, Wu J, Runnels JM, et al. Direct
measurement of local oxygen concentration in the bone marrow of live
animals. Nature (2014) 508(7495):269–73.
Mader JT, Brown GL, Guckian JC, Wells CH, Reinarz JA. A mechanism for
the amelioration by hyperbaric oxygen of experimental staphylococcal
osteomyelitis in rabbits. J Infect Dis (1980) 142(6):915–22.
Gabig TG, Bearman SI, Babior BM. Effects of oxygen tension and pH on the
respiratory burst of human neutrophils. Blood (1979) 53(6):1133–9.
Colgan SP, Taylor CT. Hypoxia: an alarm signal during intestinal
inﬂammation. Nat Rev Gastroenterol Hepatol (2010) 7(5):281–7.
Wilde AD, Snyder DJ, Putnam NE, Valentino MD, Hammer ND, Lonergan
ZR, et al. Bacterial Hypoxic Responses Revealed as Critical Determinants of
the Host-Pathogen Outcome by TnSeq Analysis of Staphylococcus aureus
Invasive Infection. PloS Pathog (2015) 11(12):e1005341.
Yarwood JM, McCormick JK, Schlievert PM. Identiﬁcation of a novel twocomponent regulatory system that acts in global regulation of virulence
factors of Staphylococcus aureus. J Bacteriol (2001) 183(4):1113–23.
Tiwari N, Lopez-Redondo M, Miguel-Romero L, Kulhankova K, Cahill MP,
Tran PM, et al. The SrrAB two-component system regulates Staphylococcus
aureus pathogenicity through redox sensitive cysteines. Proc Natl Acad Sci
USA (2020) 117(20):10989–99.
Kinkel TL, Roux CM, Dunman PM, Fang FC. The Staphylococcus aureus
SrrAB two-component system promotes resistance to nitrosative stress and
hypoxia. mBio (2013) 4(6):e00696–13.
Pagels M, Fuchs S, Pane-Farre J, Kohler C, Menschner L, Hecker M, et al.
Redox sensing by a Rex-family repressor is involved in the regulation of
anaerobic gene expression in Staphylococcus aureus. Mol Microbiol (2010)
76(5):1142–61.
Heim CE, Bosch ME, Yamada KJ, Aldrich AL, Chaudhari SS, Klinkebiel D,
et al. Lactate production by Staphylococcus aureus bioﬁlm inhibits HDAC11
to reprogramme the host immune response during persistent infection. Nat
Microbiol (2020) 5(10):1271–84.
Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic
regulation of gene expression by histone lactylation. Nature (2019) 574
(7779):575–80.
Liberti MV, Locasale JW. Histone Lactylation: A New Role for Glucose
Metabolism. Trends Biochem Sci (2020) 45(3):179–82.
Williams ER. Lactylation drives resolution. Sci Signaling (2019) 12(606):
eaba0502.
Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, et al.
Trained immunity: A program of innate immune memory in health and
disease. Science (2016) 352(6284):aaf1098.
Arts RJ, Joosten LA, Netea MG. Immunometabolic circuits in trained
immunity. Semin Immunol (2016) 28(5):425–30.
van der Heijden C, Noz MP, Joosten LAB, Netea MG, Riksen NP, Keating
ST. Epigenetics and Trained Immunity. Antioxid Redox Signal (2018) 29
(11):1023–40.
Peignier A, Parker D. Trained immunity and host-pathogen interactions.
Cell Microbiol (2020) 22:e13261.
Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, et al.
Epigenetic programming of monocyte-to-macrophage differentiation and
trained innate immunity. Science (2014) 345(6204):1251086.
Feuerstein R, Forde AJ, Lohrmann F, Kolter J, Ramirez NJ, Zimmermann J,
et al. Resident macrophages acquire innate immune memory in
staphylococcal skin infection. Elife (2020) 9:e55602. doi: 10.7554/eLife.55602
Chan LC, Rossetti M, Miller LS, Filler SG, Johnson CW, Lee HK, et al.
Protective immunity in recurrent Staphylococcus aureus infection reﬂects

February 2021 | Volume 11 | Article 621750

Horn and Kielian

157.

158.

159.

160.

161.

162.

163.

Host-Pathogen Metabolic Crosstalk

164. Kriegeskorte A, Grubmuller S, Huber C, Kahl BC, von Eiff C, Proctor RA,
et al. Staphylococcus aureus small colony variants show common metabolic
features in central metabolism irrespective of the underlying auxotrophism.
Front Cell Infect Microbiol (2014) 4:141.
165. Acker KP, Wong Fok Lung T, West E, Craft J, Narechania A, Smith H, et al.
Strains of Staphylococcus aureus that Colonize and Infect Skin Harbor
Mutations in Metabolic Genes. iScience (2019) 19:281–90.
166. Kitur K, Wachtel S, Brown A, Wickersham M, Paulino F, Penaloza HF, et al.
Necroptosis Promotes Staphylococcus aureus Clearance by Inhibiting
Excessive Inﬂammatory Signaling. Cell Rep (2016) 16(8):2219–30.
167. Lagziel S, Gottlieb E, Shlomi T. Mind your media. Nat Metab (2020) 2:1369–
72.
168. Artyomov MN, Van den Bossche J. Immunometabolism in the Single-Cell
Era. Cell Metab (2020) 32:710–25.
169. Arguello RJ, Combes AJ, Char R, Gigan JP, Baaziz AI, Bousiquot E, et al.
SCENITH: A Flow Cytometry-Based Method to Functionally Proﬁle Energy
Metabolism with Single-Cell Resolution. Cell Metab (2020) 32(6):1063–75.e7.

localized immune signatures and macrophage-conferred memory. Proc Natl
Acad Sci USA (2018) 115(47):E11111–9.
Chan LC, Chaili S, Filler SG, Miller LS, Solis NV, Wang H, et al. Innate
Immune Memory Contributes to Host Defense against Recurrent Skin and
Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus
aureus. Infect Immun (2017) 85(2):e00876–16.
Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, et al. IDH
mutation impairs histone demethylation and results in a block to cell
differentiation. Nature (2012) 483(7390):474–8.
Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, et al. Inhibition of alpha-KGdependent histone and DNA demethylases by fumarate and succinate that
are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev
(2012) 26(12):1326–38.
Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, et al.
Bacille Calmette-Guerin induces NOD2-dependent nonspeciﬁc protection
from reinfection via epigenetic reprogramming of monocytes. Proc Natl
Acad Sci USA (2012) 109(43):17537–42.
Arts RJ, Blok BA, Aaby P, Joosten LA, de Jong D, van der Meer JW, et al.
Long-term in vitro and in vivo effects of gamma-irradiated BCG on innate
and adaptive immunity. J Leukoc Biol (2015) 98(6):995–1001.
Arts RJ, Novakovic B, Ter Horst R, Carvalho A, Bekkering S, Lachmandas E,
et al. Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic
and Epigenetic Programs in Trained Immunity. Cell Metab (2016) 24
(6):807–19.
Wong Fok Lung T, Monk IR, Acker KP, Mu A, Wang N, Riquelme SA, et al.
Staphylococcus aureus small colony variants impair host immunity by
activating host cell glycolysis and inducing necroptosis. Nat Microbiol
(2020) 5(1):141–53.

Frontiers in Immunology | www.frontiersin.org

Conﬂict of Interest: The authors declare that the research was conducted in the
absence of any commercial or ﬁnancial relationships that could be construed as a
potential conﬂict of interest.
Copyright © 2021 Horn and Kielian. This is an open-access article distributed under
the terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal is
cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.

13

February 2021 | Volume 11 | Article 621750

